Incyte Data at the European Academy of Dermatology and Venereology (EADV) Congress Underscore the Breadth of Incyte’s Inflammation and Autoimmunity Portfolio
WILMINGTON, Del. --(BUSINESS WIRE)--Sep. 22, 2026-- Incyte (Nasdaq:INCY) today announced that data from across its Inflammation and Autoimmunity (IAI) portfolio will be presented at the European Academy of Dermatology and Venereology (EADV) 2026, held September 30 - October 3, 2026, in Vienna,
Presentation / Abstract • Phase 3EADV poster presentations Wed, Sep 30, 2026, 1:00 AM ETMatched ruxolitinib, cream, vitiligo, nonsegmental